Epidermal growth factor receptor – targeted molecular therapeutics for head and neck squamous cell carcinoma

Author： Egloff Ann Marie Grandis Jennifer

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.10, Iss.5, 2006-10, pp. : 639-647

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Squamous Cell Carcinoma of the Head and Neck in the Metastatic and Refractory Settings: Advances in Chemotherapy and the Emergence of Small Molecule Epidermal Growth Factor Receptor Kinase Inhibitors

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 666-673

Bentham Science Publishers

Access to resources Recommend Favorite

Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma

By Cassell Andre Grandis Jennifer R

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 6, 2010-06 ,pp. : 709-722

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic and Preventive Effects of an Epidermal Growth Factor Receptor Inhibitor on Oral Squamous Cell Carcinoma

By Ge H Liu H Fu Z Sun Z

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 455-466

Field House Publishing

Access to resources Recommend Favorite

Pharmacotherapy for squamous-cell carcinoma of the head and neck

By Papaspyrou Giorgos Werner Jochen A Dietz Andreas

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 397-409

Informa Healthcare

Access to resources Recommend Favorite

Afatinib in the treatment of head and neck squamous cell carcinoma

By Ferrarotto Renata Gold Kathryn A

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 135-143

Informa Healthcare

Access to resources Recommend Favorite